Wellington Biomedical Innovation Investors (Cayman) I L.P. — Form D/A
Wellington Biomedical Innovation Investors (Cayman) I L.P. of Grand Cayman, E9, a pooled investment fund, filed a Form D amendment with the SEC on 2020-09-03. $19.6M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-09-03
- Form: D/A
- Accession: 0000899140-20-000400
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $19.6M
- Investors: 9
- Date of first sale: 2019-12-20
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-350307
Issuer
- Name: Wellington Biomedical Innovation Investors (Cayman) I L.P.
- CIK: 0001787089
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2019
- Address: Ogier Global (Cayman) Limited, Grand Cayman, E9, KY1-9009
- Phone: (617) 951-5372
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| -- Wellington Alternative Investments LLC | Executive Officer | Boston, MA |
| -- Wellington Management Company LLP | Executive Officer | Boston, MA |
| -- Wellington Management Investment, Inc. | Executive Officer | Boston, MA |
| -- Wellington Alternative Investments LLC | Promoter | Boston, MA |
| -- Wellington Management Company LLP | Promoter | Boston, MA |
Other filings by this issuer (1)
More